Detalhe da pesquisa
1.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692409
2.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335916
3.
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
N Engl J Med
; 383(17): 1613-1623, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085860
4.
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
Ann Hematol
; 97(10): 1767-1774, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947973
5.
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.
Br J Haematol
; 176(2): 258-267, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27391055
6.
Cardiovascular events and intensity of treatment in polycythemia vera.
N Engl J Med
; 368(1): 22-33, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23216616
7.
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Blood
; 124(19): 2930-6, 2014 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25232059
8.
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
Am J Hematol
; 91(6): 617-22, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26971721
9.
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
Am J Hematol
; 89(2): 119-24, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122886
10.
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.
J Clin Oncol
; 42(8): 881-885, 2024 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127722
11.
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
Clin Lymphoma Myeloma Leuk
; 24(5): 323-331, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369436
12.
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.
Haematologica
; 98(2): 239-46, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065521
13.
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.
Eur J Haematol
; 90(4): 345-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23336938
14.
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers.
Am J Hematol
; 93(9): E243-E246, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981267
15.
Role of Diacylglycerol Kinases in Acute Myeloid Leukemia.
Biomedicines
; 11(7)2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509516
16.
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies.
Cancers (Basel)
; 15(18)2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760587
17.
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
Cancers (Basel)
; 15(18)2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760592
18.
Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program.
Cancer
; 118(4): 1014-22, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21761399
19.
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
Br J Haematol
; 156(2): 205-12, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22082314
20.
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.
Blood Adv
; 6(6): 1742-1753, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649276